India likely to approve AstraZeneca vaccine by next week as SII submits new data: Report
India likely to approve AstraZeneca vaccine by next week as SII submits new data: Report
India is likely to approve Oxford/AstraZeneca s coronavirus vaccine for emergency use by next week after Serum Institute of India (SII) submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.
advertisement
UPDATED: December 23, 2020 10:45 IST
India could be the first country to give the regulatory green light for the AstraZeneca vaccine. (Reuters)
India is likely to approve Oxford/AstraZeneca s coronavirus vaccine for emergency use by next week after Serum Institute of India (SII) submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.
2-MIN READ
Govt Likely to Approve AstraZeneca Covid-19 Vaccine by Next Week: Sources
Vials with a sticker reading, COVID-19 / Coronavirus vaccine / Injection only and a medical syringe are seen in front of an AstraZeneca logo. (REUTERS/Dado Ruvic/Illustration/File Photo)
India is likely to approve Oxford/AstraZeneca s coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.
FOLLOW US ON:
India is likely to approve Oxford/AstraZeneca’s coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.
Neha Arora, Krishna N. Das
4 分钟阅读
NEW DELHI, Dec 22 (Reuters) - India is likely to approve Oxford/AstraZeneca’s coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.
This could be the first country to give the regulatory green light for the British drugmaker’s vaccine as the British medicine regulator continues to examine data from the trials.
India, the world’s biggest vaccine-making country, wants to start inoculating its citizens next month and is also considering emergency use authorisation applications for vaccines made by Pfizer Inc and local company Bharat Biotech.
NEW DELHI: India is likely to approve Oxford/AstraZeneca’s coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.
This could be the first country to give the regulatory green light for the British drugmaker’s vaccine as the British medicine regulator continues to examine data from the trials.
India, the world’s biggest vaccine-making country, wants to start inoculating its citizens next month and is also considering emergency use authorisation applications for vaccines made by Pfizer Inc and local company Bharat Biotech.
Updated Dec 23, 2020 | 10:52 IST
The Oxford-AstraZeneca COVID-19 vaccine has emerged as a frontrunner in the race of COVID vaccines. It is dubbed Covishield in India. The vaccine is reportedly likely to receive approval in India by next week. India may have first COVID vaccine soon, emergency use approval for Oxford-AstraZeneca expected by next week | Photo Credit: iStock Images
New Delhi: India is likely to approve the first COVID-19 vaccine in the country for emergency use. The Oxford-AstraZeneca COVID vaccine candidate, being tested and produced by the Serum Institute of India, Pune, is likely to receive approvals for emergency use by next week. SII has submitted the additional data sought by authorities, news agency Reuters reported.